Paper Details

  1. Home
  2. Paper Details

Predictors for symptom re-exacerbation after targeted stepwise drug discontinuation in first-episode schizophrenia: Results of the first-episode study within the German research network on schizophrenia.

Author: EickhoffMatthias, FalkaiPeter, GaebelWolfgang, KlimkeAnsgar, KlingbergStefan, MaierWolfgang, MöllerHans-Jürgen, RiedelMichael, RiesbeckMathias, RuhrmannStephan, SauerHeinrich, SchmittAndrea, WölwerWolfgang, de MillasWalter, von WilmsdorffMartina

Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This research examines the use of targeted intermittent treatment (IT) for schizophrenia, specifically after a first episode. While maintenance treatment (MT) is generally recommended, the study investigates the feasibility of IT, considering the potential adverse effects of antipsychotics and patient preferences.
Paper Details　
Original Abstract of the Article :
After a first episode in schizophrenia guidelines recommend antipsychotic maintenance treatment (MT) for at least 1year. Recent RCTs on subsequent targeted intermittent treatment (IT) after stepwise drug discontinuation yielded noticeably higher relapse rates than during MT also in first-episode pat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.schres.2015.10.024

データ提供：米国国立医学図書館（NLM）

Predicting Symptom Re-Exacerbation in First-Episode Schizophrenia: Navigating the Uncertain Landscape

This study investigates the challenges of managing schizophrenia, a condition that can be like navigating a vast and unpredictable desert. The researchers are seeking to identify predictors for symptom re-exacerbation after targeted stepwise drug discontinuation, which is like finding reliable landmarks that can help us navigate the treacherous terrain.

Identifying Patients at Risk of Relapse

This study focused on patients experiencing a first episode of schizophrenia and aimed to identify factors that could predict symptom re-exacerbation after reducing or discontinuing medication. The researchers found that while some patients remained stable after discontinuation, others experienced symptom re-exacerbation. This is like navigating a desert with hidden sandstorms – some paths are safe, while others pose a greater risk. Identifying these risk factors is crucial for developing personalized treatment plans and minimizing the chances of relapse.

Navigating the Uncertainties of Schizophrenia Treatment

The study highlights the need for a personalized approach to managing schizophrenia, taking into account the individual patient's risk factors and response to treatment. It's like choosing the right path through the desert, taking into account the unique challenges and resources available to each traveler. This research provides valuable insights into the complexities of schizophrenia treatment and offers hope for improving outcomes for patients.

Dr.Camel's Conclusion

This study sheds light on the complexities of managing schizophrenia, emphasizing the need for personalized treatment approaches and careful monitoring to minimize the risk of symptom re-exacerbation. It's like recognizing that even in a seemingly barren desert, there are paths to follow that can lead to a more stable and fulfilling journey.
Date :
  1. Date Completed 2016-11-02
  2. Date Revised 2022-03-18
Further Info :

Pubmed ID

26607102

DOI: Digital Object Identifier

10.1016/j.schres.2015.10.024

Related Literature

Article Analysis
・Effective treatment of schizophrenia
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.